Overview
What is International Myeloma Foundation?
The International Myeloma Foundation (IMF) is a California-based nonprofit organization with a mission to lead collaborative myeloma research globally. Since 1995, they have funded over 151 grants for top research scientists, and their International Myeloma Working Group brings together experts to publish groundbreaking research, mentor future investigators, and improve care for myeloma patients. The Black Swan Research Initiative is a consortium of leading myeloma experts utilizing advanced technologies and treatments to develop new curative therapies. IMF is dedicated to enhancing the lives of myeloma patients, pursuing prevention and a cure. With a team of 43 employees, their work drives progress towards a myeloma-free future.
Official website here: www.myeloma.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 96% (Four-Star out of Four Stars)
The International Myeloma Foundation (IMF) holds an impressive 96% rating on Charity Navigator, reflecting its strong accountability and financial management. With a high program expense ratio and efficient fundraising, the organization demonstrates a robust commitment to utilizing its resources effectively for its mission. The leadership's adaptability and the independent nature of its board also contribute to its credibility, ensuring that the organization remains focused on its goals without conflicts of interest.
User feedback highlights the IMF's significant impact on the lives of multiple myeloma patients and their families. Many reviewers praise the organization for its caring and dedicated staff, as well as the wealth of educational resources it provides. Programs such as the hotline, patient seminars, and support group assistance are frequently mentioned as invaluable tools for those navigating the complexities of the disease. The IMF is recognized not only for its informational support but also for its role in fostering community among patients.
While the overall sentiment is overwhelmingly positive, some feedback suggests challenges related to ongoing funding for feedback collection, indicating a potential area for improvement. Nevertheless, the IMF's commitment to education, research, and patient support solidifies its reputation as a leading nonprofit in the myeloma community.
This AI summary has been generated from information found on Charity Navigator and Great Nonprofits.
Is International Myeloma Foundation legitimate?
International Myeloma Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. International Myeloma Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $1,065,367
Professional Fundraising Fees: $0
Other Salaries and Wages: $6,601,162
For more financial information, click here
Official website here: www.myeloma.org
What is the mission statement of International Myeloma Foundation?
The International Myeloma Foundation is committed to enhancing the lives of myeloma patients as they strive towards finding prevention and a cure. The organization is at the forefront of collaborative myeloma research, funding over 151 grants for esteemed research scientists since 1995. They bring together leading experts in the field through the International Myeloma Working Group, driving groundbreaking research and shaping the path to a cure. The Black Swan Research Initiative, a consortium of top myeloma experts, is harnessing new technologies and innovative treatments to discover cure pathways. The Black Swan Research Strategy focuses on making the most of novel therapies and ultra-sensitive tests to monitor therapy progression in patients. The International Myeloma Foundation is dedicated to developing new curative therapies for myeloma.
Official website here: www.myeloma.org
Who is the CEO of International Myeloma Foundation?
Yelak Biru is the Director of International Myeloma Foundation. The CEO's salary of International Myeloma Foundation is $203,321 and their total compensation is $203,348.
Official website here: www.myeloma.org
What is the revenue of International Myeloma Foundation?
International Myeloma Foundation's revenue in 2022 was $18,062,675.
Official website here: www.myeloma.org
Who are the executives of International Myeloma Foundation and what are their salaries?
The average compensation at International Myeloma Foundation during 2022 was $178,291. There are 43 employees at International Myeloma Foundation.
Here are 23 key members and their salaries (International Myeloma Foundation's CEO's salary is $203,321 and their total compensation is $203,348):
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $259,754
- Related: $0
- Other: $29,204
- Compensation: $203,321
- Related: $0
- Other: $27
- Compensation: $288,360
- Related: $0
- Other: $18,793
- Compensation: $512,891
- Related: $0
- Other: $14,689
- Compensation: $480,469
- Related: $0
- Other: $16,117
- Compensation: $244,167
- Related: $0
- Other: $22,504
- Compensation: $236,261
- Related: $0
- Other: $37
Official website here: www.myeloma.org
Where can I find the form 990 for International Myeloma Foundation?
International Myeloma Foundation's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.myeloma.org
Learn more at the official website: www.myeloma.org
Mission Statement of International Myeloma Foundation
The International Myeloma Foundation (IMF) is a leading organization dedicated to enhancing the quality of life of myeloma patients and relentlessly pursuing prevention and a cure. With a focus on collaborative myeloma research, IMF has awarded over 151 research grants to distinguished scientists since its inception in 1995. The organization brings together the world's foremost myeloma experts through the International Myeloma Working Group. Together, they publish groundbreaking research in prestigious medical journals, chart the course to a cure, mentor the next generation of innovative investigators, and improve lives through better care.
Moreover, IMF's Black Swan Research Initiative is a multinational consortium of leading myeloma experts harnessing new technologies and the latest myeloma treatments to discover a pathway to a cure. This research strategy capitalizes on the availability of potent novel therapies and the advent of ultra-sensitive tests to measure precisely when and how those therapies are effective in patients. The Black Swan Research Initiative is fully committed to developing new curative therapies for myeloma. The International Myeloma Foundation's unwavering dedication, collaboration, and innovative spirit have made significant strides in the quest for a myeloma cure.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The International Myeloma Foundation significantly enhances the quality of life for myeloma patients while pursuing pathways to prevention and a cure. Its leadership in collaborative myeloma research has been pivotal, issuing over 151 grants since 1995 to both junior and senior scientists committed to advancing the field. By fostering a global network of experts through the International Myeloma Working Group, the Foundation ensures that cutting-edge research is published in prestigious medical journals, ultimately shaping the future of myeloma treatment and care.
Additionally, the Black Swan Research Initiative exemplifies a focused effort towards discovering new curative therapies for myeloma. This multinational consortium utilizes advanced technologies and innovative treatments to precisely measure the effectiveness of therapies on patients, paving the way for more targeted and successful interventions. Through these initiatives, the Foundation not only seeks to improve patient outcomes but is also dedicated to mentoring the next generation of researchers, ensuring a sustainable future for advancements in myeloma treatment.
This information is meant to be a general summary of International Myeloma Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $247,858
- Program Service Revenue: $6,770
- Gross Receipts: $18,062,675
Assets and Liabilities:
- Total Assets: $18,463,467
- Total Liabilities: $6,761,429
- Net Assets: $11,702,038
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
SUPPORT GROUP
Revenue
$6,770
Organization Details
Founding Year
1990
Phone
(818) 487-7455Principal Officer
Yelak Biru
Main Address
4400 COLDWATER CANYON AVE 300, STUDIO CITY, CA, 91604
Website
www.myeloma.orgNTEE Category
Code: Z99Z - Unknown
If you are a representative of International Myeloma Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.